Canyon Capital Advisors FY2025 10-K Annual Report

Filed: Feb 19, 2026
Financials
Life InsuranceSEC EDGAR

Canyon Capital Advisors 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 19, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Canyon Capital Advisors FY2025 10-K Analysis

Business Overview

  • Core business model: Global financial services leader providing insurance, annuities, employee benefits, and asset management across multiple regions
  • New segment reporting: MetLife Investment Management (MIM) spun out as a separate reportable segment in 2025 after reorganization supporting asset management growth
+3 more insights

Management Discussion & Analysis

  • Revenue details and YoY change not explicitly disclosed in provided MD&A excerpt
  • Operating (direct) expense ratio target 12.1% for 2026 vs 11.3% target in 2029; adjusted ROE target 15%-17% for 2026
+3 more insights

Risk Factors

  • Regulatory risk: New York insurance regulator’s annual SCL asset adequacy testing may require increased reserves, affecting statutory capital and surplus
  • Geopolitical/macro risk: U.S. federal debt limit disagreements risk government shutdown or default, causing market volatility and reduced economic activity
+3 more insights

Canyon Capital Advisors FY2025 Key Financial Metrics
XBRL

Revenue

$2.4B

+8.5% YoY

Net Income

$3.4B

-23.7% YoY

Operating Margin

251.9%

-1515bp YoY

Net Margin

138.7%

-5844bp YoY

ROE

11.9%

-423bp YoY

Total Assets

$745.2B

+10.0% YoY

EPS (Diluted)

$4.71

-20.7% YoY

Operating Cash Flow

$17.1B

+17.1% YoY

Source: XBRL data from Canyon Capital Advisors FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Canyon Capital Advisors

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.